NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 - Clinical Trial Optional)
Funding Opportunity PAR-18-542 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, cell therapies, and novel emerging therapies) for disorders identified under the NINDS mission. An identified clinical candidate with sufficient bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the desired clinical application, is required for entry to this C...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2017 Category: Research Source Type: funding
Notice of Change to Expiration Date in NOT-TR-17-019 "Request for Information (RFI): Opportunities and Challenges for Platform Vector Human Gene Therapy Trials in Rare Diseases"
Notice NOT-TR-17-024 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2017 Category: Research Source Type: funding
NHLBI Research Career Development Program in HIV-Related Heart, Lung, Blood and Sleep Research (K12)
Funding Opportunity RFA-HL-18-006 from the NIH Guide for Grants and Contracts. The goal of the K12 Institutional Career Development Program in HIV-related Heart, Lung, Blood, and Sleep (HLBS) research is to encourage institutions to develop and sustain programs that support inter-disciplinary, intensive mentored research training and career development for junior PhDs and MDs in AIDS co-morbidities as well as cell and gene therapies for HIV cure and prevention of HIV transfusion transmission. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 30, 2017 Category: Research Source Type: funding
NINDS CREATE Bio Optimization Track for Biologics (U44)
Funding Opportunity PAR-17-457 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports SBIRs in the optimization of potential therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, cell therapies, and novel emerging modalities) for disorders identified under the NINDS mission. This track supports the further characterization and optimization of therapeutic agent(s) that showed promise as evidenced by relevant, rigorous, convincing in vivo studies. Therefore, at the end of this funding period, successful projects will have de...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 14, 2017 Category: Research Source Type: funding
Request for Information: Opportunities and Challenges for Platform Vector Human Gene Therapy Trials in Rare Diseases
Notice NOT-TR-17-019 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 18, 2017 Category: Research Source Type: funding
NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)
Funding Opportunity ID: 259794 Opportunity Number: PAR-14-289 Opportunity Title: NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.853Eligible Applicants: Small businessesAdditional Information on Eligibility: Other Eligible Applicants include the following:Only United States small business concerns (SBCs) are eligible to submit applic...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding
NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U44)
Funding Opportunity ID: 259793 Opportunity Number: PAR-14-287 Opportunity Title: NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U44)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.853Eligible Applicants: Small businessesAdditional Information on Eligibility: Other Eligible Applicants include the following:Only United States small business concerns (SBCs) are eligible to submit applications f...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding
NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U01)
Funding Opportunity ID: 259790 Opportunity Number: PAR-14-286 Opportunity Title: NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U01)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.853Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative Ameri...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding
NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)
Funding Opportunity ID: 259796 Opportunity Number: PAR-14-288 Opportunity Title: NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.853Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher education...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding
NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24)
Funding Opportunity ID: 291041 Opportunity Number: PAR-17-099 Opportunity Title: NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.867Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American triba...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding
NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24)
Funding Opportunity PAR-17-099 from the NIH Guide for Grants and Contracts. In the context of this program, an expert assembles a multi-disciplinary research team that uses an integrative approach to develop rapid and efficient translation of innovative laboratory research findings into therapies, devices or other resources for use by clinicians to treat visual system diseases or disorders. It involves collaborative teams of scientists and clinicians with expertise in multiple disciplines, operating according to a clear leadership plan. Such a collaborative approach is particularly appropriate for research focused on pa...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 5, 2017 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for the Blood and Marrow Transplant Clinical Trials Network Data Coordinating Center (U24)
Opportunity ID: 284875 Opportunity Number: NOT-HL-16-314 Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for the Blood and Marrow Transplant Clinical Trials Network Data Coordinating Center (U24)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.839Eligible Applicants: State governmentsCounty governmentsCity or township governmentsIndependent school districtsPublic and State controlled institutions of higher ...
Source: Grants.gov - June 18, 2016 Category: Research Tags: Health Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Core Clinical Centers for the Bone and Marrow Transplant Clinical Trials Network (U10)
Opportunity ID: 284876 Opportunity Number: NOT-HL-16-315 Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for Core Clinical Centers for the Bone and Marrow Transplant Clinical Trials Network (U10)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.839Eligible Applicants: State governmentsCounty governmentsCity or township governmentsIndependent school districtsPublic and State controlled institutions of higher ...
Source: Grants.gov - June 18, 2016 Category: Research Tags: Health Source Type: funding
Request for Proposals: National Tay-Sachs & Allied Diseases Association Research Grant Program
Request for Proposals: National Tay-Sachs & Allied Diseases Association Research Grant Program The National Tay- Sachs & Allied Diseases Association Inc. (NTSAD) is considered to be the nation’s oldest genetic disease nonprofit organization. The “Allied Diseases” represent a family of almost 100 rare diseases including lysosomal storage diseases (LSD) and leukodystrophies affecting the central nervous system. A major element of NTSAD’s mission is to lead the fight to treat and cure Tay-Sachs, Canavan and related genetic diseases; therefore, NTSAD is committed to funding research pr...
Source: ScanGrants feed - December 9, 2014 Category: Research Authors: National Tay-Sachs & Allied Diseases Association Source Type: funding
